Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: Study to Assess Safety and Tolerability of Multiple Doses of EO2002 [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety and tolerability of multiple doses of EO2002 in patients with corneal edema and related endothelial diseases; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EO2002

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Corneal Edema, Corneal Endothelial Dystrophy | Phase 1 | Status: RECRUITING